Mi Ra Yu
4PUBLICATIONS
49CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Sep 13, 2024
NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations.Jessica J Lin, Joshua C Horan, Anupong Tangpeerachaikul
|May 08, 2024
D3S-001, a KRAS G12C Inhibitor with Rapid Target Engagement Kinetics, Overcomes Nucleotide Cycling, and Demonstrates Robust Preclinical and Clinical Activities.Jing Zhang, Sun Min Lim, Mi Ra Yu
|Oct 21, 2022
Preclinical Study of a Biparatopic METxMET Antibody-Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC.Seung Yeon Oh, You Won Lee, Eun Ji Lee
|Sep 26, 2020
Fusobacterium nucleatum Accelerates the Progression of Colitis-Associated Colorectal Cancer by Promoting EMT.Mi Ra Yu, Hye Jung Kim, Hae Ryoun Park
Pageof 1
Frequent Collaborators
3 joint publications
Byoung Chul Cho
2 joint publications
Sun Min Lim
1 joint publications
Hye Jung Kim
1 joint publications
Hae Ryoun Park
1 joint publications
Seung Yeon Oh
1 joint publications
You Won Lee
1 joint publications
Eun Ji Lee
1 joint publications
Jae Hwan Kim
1 joint publications
Alexander Drilon
1 joint publications
Seong Gu Heo
